Together Pharma Ltd (TLV:TGTR)
Israel · Delayed Price · Currency is ILS · Price in ILA 349.90
+5.20 (1.51%)
At close: Jan 30, 2026
Together Pharma Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -6.56 | -1.17 | -4.32 | -33.52 | -13.78 | 7.15 |
Depreciation & Amortization | 6.96 | 6.83 | 6.51 | 6 | 5.48 | 4.24 |
Other Amortization | 3.71 | 3.71 | 17.34 | 14.3 | 12.25 | 9.47 |
Loss (Gain) From Sale of Assets | - | - | - | - | -0 | 0.04 |
Loss (Gain) From Sale of Investments | - | - | -0.22 | - | - | - |
Loss (Gain) on Equity Investments | - | - | 0.47 | 0 | - | - |
Stock-Based Compensation | - | - | - | - | 1.45 | 4.09 |
Other Operating Activities | -3.59 | -3.22 | 4.59 | -0.95 | -13.36 | -3.58 |
Change in Accounts Receivable | -8.59 | -4.36 | -4.28 | -7.44 | 0.42 | -1.34 |
Change in Inventory | 9.24 | -0.67 | -10.5 | 3.4 | -9.8 | -33.18 |
Change in Accounts Payable | 7.43 | 7.17 | 4.41 | 2.96 | -1.15 | 2.89 |
Change in Other Net Operating Assets | 1.08 | -5.45 | 0.82 | 1.51 | -0.16 | 0.5 |
Operating Cash Flow | 9.69 | 2.85 | 14.83 | -13.73 | -18.64 | -9.7 |
Operating Cash Flow Growth | -23.47% | -80.79% | - | - | - | - |
Capital Expenditures | -0.47 | -1.48 | -0.87 | -0.33 | -1.53 | -13.75 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.01 | 0.12 |
Cash Acquisitions | -1.67 | - | - | - | - | - |
Sale (Purchase) of Intangibles | -4.03 | -0.16 | -0.15 | -0.41 | -0.1 | -5.6 |
Investment in Securities | - | 0.45 | - | - | - | - |
Other Investing Activities | -0.04 | -0.2 | -0.6 | 33.79 | -27.23 | -8.66 |
Investing Cash Flow | -6.22 | -1.39 | -1.62 | 33.05 | -28.85 | -27.9 |
Long-Term Debt Issued | - | 100.74 | 78.06 | 50.35 | 38.92 | 37.34 |
Total Debt Issued | 113.55 | 100.74 | 78.06 | 50.35 | 38.92 | 37.34 |
Short-Term Debt Repaid | - | - | - | - | - | -0.04 |
Long-Term Debt Repaid | - | -97.58 | -92.28 | -80.22 | -11.84 | -6.36 |
Total Debt Repaid | -115.26 | -97.58 | -92.28 | -80.22 | -11.84 | -6.39 |
Net Debt Issued (Repaid) | -1.71 | 3.16 | -14.22 | -29.87 | 27.09 | 30.94 |
Issuance of Common Stock | 0.21 | 0.21 | - | 11.53 | 24.73 | 10.08 |
Other Financing Activities | - | - | -0.7 | -0.8 | -2.97 | -0.8 |
Financing Cash Flow | -1.5 | 3.37 | -14.92 | -19.14 | 48.84 | 40.23 |
Foreign Exchange Rate Adjustments | 0.01 | 0.02 | 0 | 0.03 | -0.01 | -0.01 |
Net Cash Flow | 1.98 | 4.85 | -1.7 | 0.2 | 1.34 | 2.62 |
Free Cash Flow | 9.21 | 1.37 | 13.97 | -14.07 | -20.17 | -23.46 |
Free Cash Flow Growth | -14.87% | -90.16% | - | - | - | - |
Free Cash Flow Margin | 8.44% | 1.43% | 15.35% | -45.04% | -167.75% | -208.99% |
Free Cash Flow Per Share | 0.66 | 0.11 | 1.59 | -1.73 | -2.94 | -4.07 |
Cash Interest Paid | 6.7 | 4.87 | 4.44 | 2.23 | 2.74 | 1.08 |
Levered Free Cash Flow | 11.8 | 2.55 | 16.46 | 29.15 | -38.12 | -30.36 |
Unlevered Free Cash Flow | 13.24 | 4.76 | 11.36 | 25.6 | -41.12 | -32.42 |
Change in Working Capital | 9.17 | -3.31 | -9.55 | 0.44 | -10.69 | -31.12 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.